文献速递血栓与止血

抗凝格局的变化:聚焦直接口服抗凝药

Changes in the landscape of anticoagulation: a focus on direct oral anticoagulants.
PubMed 文献 · Lancet Haematol · 2024-10-18

过去十年,直接口服抗凝药(DOAC)迅速改变了抗凝治疗格局。2010年代初DOAC广泛用于房颤卒中预防和静脉血栓栓塞症治疗,约10年后需口服抗凝治疗的患者中约三分之二接受DOAC。上市后研究一致证实3期临床试验结果,研究聚焦新领域但结果异质。DOAC在外周动脉疾病、癌症相关血栓、少见部位静脉血栓栓塞症和终末期肾病中显现作用,但在瓣膜性房颤、机械心脏瓣膜、不明来源栓塞性卒中或抗磷脂综合征患者中无效。

要点

  • 约10年后需口服抗凝治疗的患者中约三分之二接受DOAC。
  • 上市后研究一致证实3期临床试验结果,新领域研究结果异质。
  • DOAC在瓣膜性房颤、机械心脏瓣膜、不明来源栓塞性卒中或抗磷脂综合征患者中无效。

核心结论

  • DOAC在过去十年迅速改变抗凝治疗格局,约10年后约三分之二需口服抗凝治疗的患者接受DOAC。
  • 上市后研究一致证实3期临床试验结果,新领域研究结果异质。
  • DOAC在外周动脉疾病、癌症相关血栓、少见部位静脉血栓栓塞症和终末期肾病中显现作用。
  • 临床试验显示DOAC在瓣膜性房颤、机械心脏瓣膜、不明来源栓塞性卒中或抗磷脂综合征患者中无效。

研究设计与样本

  • 综述,讨论DOAC过去十年在临床实践中的影响、发展中新领域及药物管理实践问题。

主要发现

  • 2010年代初DOAC广泛用于房颤卒中预防和静脉血栓栓塞症治疗。
  • 约10年后约三分之二需口服抗凝治疗的患者接受DOAC。
  • 上市后研究一致证实3期临床试验结果,新领域研究结果异质。
  • DOAC在外周动脉疾病、癌症相关血栓、少见部位静脉血栓栓塞症和终末期肾病中显现作用。
  • 临床试验显示DOAC在瓣膜性房颤、机械心脏瓣膜、不明来源栓塞性卒中或抗磷脂综合征患者中无效。

临床怎么用

  • 原文未据此给出推荐。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

Over the last decade, the advent of direct oral anticoagulants (DOACs) has rapidly changed the landscape of anticoagulation. In the early 2010s, DOACs became widely available for stroke prevention in atrial fibrillation and the treatment of venous thromboembolism. About 10 years later, approximately two-thirds of patients requiring oral anticoagulant treatment were receiving a DOAC. The results of several post-marketing studies consistently confirmed the findings of phase 3 clinical trials, and research has focused on new areas of development, with heterogeneous results. A role for DOACs has emerged for patients with peripheral artery disease and other challenging conditions, such as cancer-associated thrombosis, unusual-site venous thromboembolism, and end-stage renal disease. Conversely, clinical trials showed that DOACs were not efficacious in patients with valvular atrial fibrillation, mechanical heart valves, embolic strokes of undetermined source, or antiphospholipid syndrome. In this Review, we discuss the impact of DOACs in clinical practice over the last decade, new areas under development, and practical issues in the management of these drugs.

来源:Lancet Haematol,查看原文。版权归原作者所有。

引用

  1. Ageno W, Caramelli B, Donadini MP, et al. Changes in the landscape of anticoagulation: a focus on direct oral anticoagulants. Lancet Haematol. 2024. PMID: 39433055. doi:10.1016/S2352-3026(24)00281-3

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。